<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Rodriguez-Peralvarez ML</submitter><funding>Generalitat de Catalunya</funding><funding>Consejería de Salud y Consumo, Junta de Andalucía</funding><funding>Instituto de Salud Carlos III</funding><funding>Ministerio de Ciencia y Tecnología, Gobierno de España</funding><funding>Consejería de Transformación Económica, Industria, Conocimiento y Universidades</funding><pagination>e70520</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12853322</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>46(3)</volume><pubmed_abstract>&lt;h4>Background and aims&lt;/h4>Although GEMA-Na outperforms MELD 3.0 for liver allocation, concerns about the subjectivity of its ascites component persist. We compared the performance of a GEMA-Na iteration that excludes ascites with other allocation scores.&lt;h4>Approach and results&lt;/h4>A multinational cohort study was conducted, including adult candidates for elective liver transplantation in the UK (2010-2020), Australia (1998-2020), and Spain (2016-2021). The primary outcome was mortality or delisting for sickness within 90 days. The prognostic impact of ascites was evaluated using multivariable Cox's regression. Discrimination was assessed using Harrell's c-statistics (Hc). The study included 15 391 patients (28.5% women). The prevalence of the primary outcome was 5.8% in the UK, 5.3% in </pubmed_abstract><journal>Liver international : official journal of the International Association for the Study of the Liver</journal><pubmed_title>Excluding Ascites From the GEMA-Na Score Does Not Impact Outcome Predictions in Liver Transplant Candidates.</pubmed_title><pmcid>PMC12853322</pmcid><funding_grant_id>PI22/00312</funding_grant_id><funding_grant_id>2021-SGR-01331</funding_grant_id><funding_grant_id>PID2023-150663NB-C22</funding_grant_id><funding_grant_id>PREDOC-00489</funding_grant_id><funding_grant_id>PI25/00439</funding_grant_id><pubmed_authors>Cachero A</pubmed_authors><pubmed_authors>Majumdar A</pubmed_authors><pubmed_authors>Gastaca M</pubmed_authors><pubmed_authors>Molina Perez E</pubmed_authors><pubmed_authors>Cepeda-Franco C</pubmed_authors><pubmed_authors>Kalafateli M</pubmed_authors><pubmed_authors>Rodriguez-Soler M</pubmed_authors><pubmed_authors>Guijo-Rubio D</pubmed_authors><pubmed_authors>Ortiz ML</pubmed_authors><pubmed_authors>Taylor R</pubmed_authors><pubmed_authors>Rodriguez-Peralvarez ML</pubmed_authors><pubmed_authors>Colmenero J</pubmed_authors><pubmed_authors>Martin Mateos R</pubmed_authors><pubmed_authors>Cuadrado Lavin A</pubmed_authors><pubmed_authors>Gomez-Orellana AM</pubmed_authors><pubmed_authors>Otero A</pubmed_authors><pubmed_authors>Blanco Fernandez G</pubmed_authors><pubmed_authors>Gonzalez Grande R</pubmed_authors><pubmed_authors>Romero M</pubmed_authors><pubmed_authors>Dopazo C</pubmed_authors><pubmed_authors>Arias Milla A</pubmed_authors><pubmed_authors>Tsochatzis E</pubmed_authors><pubmed_authors>Espinosa MD</pubmed_authors><pubmed_authors>Aguilera MV</pubmed_authors><pubmed_authors>Barreales M</pubmed_authors><pubmed_authors>Lorente S</pubmed_authors><pubmed_authors>Oton E</pubmed_authors><pubmed_authors>Gonzalez Dieguez L</pubmed_authors><pubmed_authors>McCaughan GW</pubmed_authors><pubmed_authors>Sogbe M</pubmed_authors><pubmed_authors>Hervas Martinez C</pubmed_authors><pubmed_authors>Alonso Martin C</pubmed_authors><pubmed_authors>de la Rosa G</pubmed_authors></additional><is_claimable>false</is_claimable><name>Excluding Ascites From the GEMA-Na Score Does Not Impact Outcome Predictions in Liver Transplant Candidates.</name><description>&lt;h4>Background and aims&lt;/h4>Although GEMA-Na outperforms MELD 3.0 for liver allocation, concerns about the subjectivity of its ascites component persist. We compared the performance of a GEMA-Na iteration that excludes ascites with other allocation scores.&lt;h4>Approach and results&lt;/h4>A multinational cohort study was conducted, including adult candidates for elective liver transplantation in the UK (2010-2020), Australia (1998-2020), and Spain (2016-2021). The primary outcome was mortality or delisting for sickness within 90 days. The prognostic impact of ascites was evaluated using multivariable Cox's regression. Discrimination was assessed using Harrell's c-statistics (Hc). The study included 15 391 patients (28.5% women). The prevalence of the primary outcome was 5.8% in the UK, 5.3% in </description><dates><release>2026-01-01T00:00:00Z</release><publication>2026 Mar</publication><modification>2026-06-13T05:28:10.386Z</modification><creation>2026-06-13T03:09:18.661Z</creation></dates><accession>S-EPMC12853322</accession><cross_references><pubmed>41608883</pubmed><doi>10.1111/liv.70520</doi></cross_references></HashMap>